PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)
$10.43 -0.28 (-2.6144%)
Analysed PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) News Sources
Phathom Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
30-04-2026
yahoo.com
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates
30-04-2026
yahoo.com
Phathom (PHAT) Q1 2026 Earnings Transcript
30-04-2026
fool.com
Phathom Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary
01-05-2026
moby.co
Phathom Pharmaceuticals Q1 Earnings Call Highlights
01-05-2026
marketbeat.com
Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting
01-05-2026
yahoo.com
How The Phathom Pharmaceuticals (PHAT) Narrative Is Shifting Around Profitability And Exclusivity Risks
03-05-2026
yahoo.com
Phathom Pharmaceuticals (PHAT) Is Up 11.0% After Narrowing Q1 Loss And Reaffirming 2026 Profitability Timeline
05-05-2026
yahoo.com
Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting
20-05-2026
yahoo.com
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
22-05-2026
yahoo.com
What is the current price of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)?
The current price of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) is $10.43.
PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) absolute price change since previous trading day?
The absolute price change of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) since the previous trading day is $-0.28.
PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) percentage price change since previous trading day?
The percentage price change of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) since the previous trading day is -2.6144%.
What is the most recent average sentiment score for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)?
The most recent average sentiment score for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)?
The most recent sentiment for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) is .
SEC-8K** Filing Available For PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.